You are here
Data on heart benefits of Amgen drug key to unlocking sales
DATA that should help unlock the sales potential of a potent new cholesterol medicine will be unveiled at the American College of Cardiology meeting this week as the future of the only rival drug rests with the courts in an ongoing patent dispute.
- CALL +65 6388 3838
- EMAIL firstname.lastname@example.org